Side Effects

GLP-1 and Burping: Why It Happens and How to Reduce It

GLP-1 Companion · 6 min read

Burping, medically termed eructation, is the audible release of gas from the esophagus or stomach through the mouth. While not among the most serious side effects of GLP-1 receptor agonists, it is one that significantly affects quality of life and social comfort. Approximately 10–15% of patients starting GLP-1 therapy report noticeable increases in burping frequency — and a subset describe a distinctly unpleasant "sulfur" or "rotten egg" quality to the gas. Understanding why this happens is the first step toward reducing it.

The Core Mechanism: Slowed Gastric Emptying and Gas Accumulation

GLP-1 receptor agonists reduce the rate of gastric emptying — the process by which food moves from the stomach into the small intestine — by 20–40%. When food and liquid remain in the stomach longer than usual, gas produced during early digestion has more time to accumulate before it can be expelled downward through the pylorus. The path of least resistance for this trapped gas becomes upward, through the esophagus, resulting in eructation.

Additionally, patients managing GLP-1-induced nausea often unconsciously swallow more air — a process called aerophagia. This swallowed air adds to the gas load in the stomach. Air swallowing tends to be worse in people who eat quickly, sip beverages frequently, chew gum, or breathe through their mouth during nausea episodes.

Why Some Patients Experience "Sulfur Burps"

A particularly distressing variant reported by some GLP-1 users is the "sulfur burp" — gas with a smell resembling hydrogen sulfide, often described as rotten eggs. This phenomenon is related to altered gut transit across the entire gastrointestinal tract. While GLP-1 medications primarily slow upper GI transit (gastric emptying), they also affect motility in the lower GI tract.

When food transits more slowly through the gut, it is exposed to gut bacteria for longer periods. Sulfur-containing amino acids in proteins — particularly methionine and cysteine found in eggs, meat, dairy, and cruciferous vegetables — undergo bacterial fermentation that produces hydrogen sulfide gas. This gas travels upward and manifests as the characteristic sulfurous odor. Patients who eat high-protein diets (as recommended for muscle preservation on GLP-1 therapy) may be particularly prone to this if transit is significantly slowed.

The Role of Carbonated Beverages

Carbonated drinks — sparkling water, soda, and carbonated protein shakes — are a major and avoidable contributor to burping on GLP-1 therapy. The dissolved carbon dioxide in these beverages is released as gas once consumed. Under normal gastric motility, this gas exits relatively quickly. On GLP-1 therapy, the slowed emptying means CO2 lingers in the stomach and has a longer window to generate burping. Switching entirely to still water and non-carbonated beverages during GLP-1 therapy can produce a noticeable reduction in burping frequency within days.

Dietary and Behavioral Strategies

The following evidence-informed strategies target the root causes of GLP-1-related burping:

1. Eliminate carbonated beverages — this is the single highest-impact dietary change for reducing burping on GLP-1 therapy.
2. Eat slowly and put your fork down between bites — rapid eating is one of the primary causes of aerophagia. Aim for meals that take at least 15–20 minutes.
3. Avoid talking while chewing — speaking with food in the mouth increases the amount of air swallowed with each swallow.
4. Eat smaller meals — reducing meal volume lowers the amount of gas that can accumulate during digestion.
5. Avoid chewing gum and sucking on hard candies — both significantly increase air swallowing.
6. Avoid drinking through straws — straw-drinking consistently introduces air into the esophagus and stomach.
7. Limit sulfur-rich foods if experiencing sulfur burps — temporarily reducing eggs, red meat, and cruciferous vegetables may help while your gut adapts.

Over-the-Counter Remedies

Simethicone (Gas-X, Phazyme) is the most commonly recommended over-the-counter remedy for gas and burping. It works by breaking down large gas bubbles in the stomach and intestines into smaller ones that are easier to pass. It is not absorbed into the bloodstream and has an excellent safety profile, making it suitable for regular use during GLP-1 dose titration. Simethicone does not address the underlying mechanism but provides symptomatic relief.

Ginger is a well-studied natural prokinetic — it mildly stimulates gastric motility and has been shown to reduce gas production in the gut. Ginger tea, ginger chews, or ginger capsules (500–1000 mg before meals) may help both nausea and gas simultaneously, making it particularly useful during the early weeks of GLP-1 therapy.

Does Burping Improve Over Time?

For most patients, burping is most pronounced during the initial weeks at each new dose level. As the body adapts to a stable dose, gastric motility typically partially normalizes and the degree of gas accumulation decreases. Clinical experience suggests that by weeks 6–8 at a stable dose, the majority of patients report a significant reduction in burping frequency. Maintaining the dietary habits described above during this adaptation period accelerates improvement.

When to Mention It to Your Provider

Burping alone rarely warrants urgent medical attention. However, you should discuss the symptom with your prescriber if:

• Burping is accompanied by significant abdominal pain, bloating, or nausea that does not respond to conservative management
• You are experiencing burping of undigested food — this can indicate gastroparesis (severely delayed gastric emptying)
• Symptoms are severe enough to interfere with work, sleep, or social activities
• There is no improvement after 8 weeks at a stable dose despite dietary modifications

Sources

• Drucker DJ (2018). Mechanisms of Action and Therapeutic Application of GLP-1. Cell Metabolism.
• Ozempic (semaglutide) Prescribing Information. Novo Nordisk.